|
|
|
|
|
»»Thursday,
April 28--»»
Friday, April 29--»»
Saturday, April 30
»» Moderated
Poster Abstract Sesssion--
»» Live
Case Operators |
|
|
Thursday
| April
28, 2005 |
Main Arena
Vista Hall, W-Hotel, Level B2
1:00 PM~6:30 PM |
| 1:00 PM |
Welcome Address |
Seung-Yun
Cho, MD
Chairman, The Korean Society of Circulation |
| Angioplasty Summit 2005-TCT
Asia Pacific Introduction |
| 1:10 PM |
Launching of The Joint
Conference - Angioplasty Summit and TCT: Significance
and Future Perspectives |
Seung-Jung Park, MD |
| 1:20 PM |
TCT Asia Pacific: Where
We Are Going... |
Martin B. Leon, MD |
| |
| TCT
Asia Pacific |
| Drug
Eluting Stent Summit-I |
| Moderators:
Martin B. Leon, MD, Seung-Jung Park, MD |
| 1:30 PM |
Are All Sirolimus Analogs
Alike? |
Robert Falotico, MD |
| 1:45 PM |
New Drug Eluting Stents
|
Alexandre Abizaid, MD |
| 2:00 PM |
Is the TAXUS Stent Benefit
Extended to the Most Complicated Patients
and Lesions? |
Eberhard Grube, MD |
| 2:15 PM |
The Perspective of Drug
Eluting Stent in the Future
|
Martin B. Leon, MD |
| 2:30 PM |
Late Loss Remains the
Best Single Indicator of DES Performance! |
Richard E. Kuntz , MD |
| 2:45 PM |
The "Appropriate"
Use of IVUS During DES Procedures |
Gary S. Mintz, MD |
| 3:00 PM |
DES Pathobiology Considerations:
What We Know and What We Don't Know Can Hurt
Us! |
Renu Virmani, MD |
| |
The
Great Debate: |
|
| 3:15 PM |
Why TAXUS Is Better ? |
Gregg W. Stone, MD |
| 3:30 PM |
Why CYPHER Is Better
? |
Martin B. Leon, MD |
| |
|
|
| 3:45 PM |
Coffee
Break |
|
|
|
| New
Clinical Trials Updates 2005 - from TCT, AHA,
ACC |
| Moderators:
Gregg W. Stone,MD, Gary S. Mintz, MD |
| 4:00 PM |
Recent Updates from the
Taxus Trials (Taxus 2 and 4 Late FU, Taxus
Meta-Analysis, and Taxus 5) |
Gregg W. Stone, MD |
| 4:15 PM |
Recent Updates from the
Cypher Trials (Cypher Meta-Analysis, Diabetes,
Late FU from FIM and SIRIUS, ARTS II) |
Alexandre Abizaid, MD |
| 4:30 PM |
A Critical Appraisal
of the "Head-to-Head" Cypher vs.
Taxus Trials |
Martin B. Leon, MD |
| 4:45 PM |
The Endeavor DES Program
(Focus on Endeavor 2) |
Richard E. Kuntz, MD |
| 5:00 PM |
The Biolimus A9 DES Program
(Focus on Stealth 1) |
Eberhard Grube, MD |
| 5:15 PM |
Discussion |
|
|
|
|
Live
Case Session 1
Asan Medical Center, Seoul, Korea : Cases
#1, #2 |
| Moderators:
Gregg W. Stone, MD, Alan C. Yeung, MD |
| 5:30 PM |
| Discussants: |
Alexandre Abizaid,
MD
Charles Chan, MD
Eberhard Grube, MD
Yang-Soo Jang, MD
Takeshi Kimura, MD
Richard E. Kuntz, MD
Ki Bae Seung, MD
Seung-Jea Tahk, MD |
|
| |
|
|
| 6:30 PM |
Adjourn |
|
|
|
|
Evening
Symposia
Sheraton Grande Walkerhill Seoul
Hotel
6:30 PM-8:30 PM |
#1.
The Future of DES and Complex PCI
Mugunghwa Room 1, Level 1
Sponsored by Boston Scientific Korea Co.,
Ltd. |
| Moderators:
Gregg W. Stone, MD, Seong-Wook Park, MD |
| 6:30 PM |
Buffet Dinner
|
|
| |
|
|
| 7:00 PM |
Opening Remark |
|
| 7:10 PM |
Taxus V Clinical Update
|
Gregg W. Stone, MD |
| 7:30 PM |
Diabetic Performance
in Taxus |
Myung-Ho Jeong, MD |
| 7:50 PM |
IVUS in Complex PCI |
Alan C. Yeung, MD |
| 8:10 PM |
Pre & Post-Dilatation
Strategies for DES |
Ted Feldman, MD |
| 8:30 PM |
Panel Discussion |
|
|
|
|
#2.
Virtual Histology; Beyond IVUS
Mugunghwa Room 2, Level 1
Sponsored by DAEIL CO., LTD |
| Moderators:
Gary S. Mintz, MD, James R. Margolis, MD |
| 6:30 PM |
Buffet Dinner
|
|
| |
|
|
| 7:00 PM |
Opening Remark |
|
| 7:10 PM |
Virtual History: Concept
and Validation |
D. Geoffrey Vince, MD |
| 7:30 PM |
Virtual Histology- A
Technical & Clinical Update |
Gary S. Mintz, MD |
| 7:50 PM |
Real World Paradigm for
Identifying Vulnerable Plaques and Vulnerable
Patients |
James R. Margolis, MD |
| 8:10 PM |
Q & A |
|
|
|
|
#3.
"ENDEAVOR"- What's New ? What's
Different ?
Cosmos Room, Level 3
Sponsored by Medtronic Korea co., Ltd |
| Moderators:
Richard E. Kuntz, MD, Ian T. Meredith, MD |
| 6:30 PM |
Buffet Dinner
|
|
| |
|
|
| 7:00 PM |
Opening Remarks, MKL
Top Management
|
Joon Hurh |
| 7:05 PM |
Overview of Endeavor
II Clinical Results |
Ian T. Meredith, MD |
| 7:20 PM |
Safety and Endeavor II
Subsets |
Richard E. Kuntz, MD |
| 7:40 PM |
Endeavor II in Perspective |
Martin B. Leon, MD |
| 8:00 PM |
Endeavor
Q & A
| Panelists
: |
In-Ho Chae, MD
Charles Chan, MD
Myeong-Ki Hong, MD
Richard E. Kuntz, MD
Ian T. Meredith, MD
John Ormiston, MD
Mohd Ali Rosli, MD
Ki Bae Seung, MD
Robaayah Zambahari, MD
|
|
|
|
|
#4.
Is Cypher the Best Choice? - Clinical Perspectives
of Cypher
Art Room, Level 4
Sponsored by Johnson & Johnson Medical
Korea Ltd. |
| Moderators:
Martin B. Leon, MD, Seung-Jung Park, MD |
| 6:30 PM |
Buffet Dinner
|
|
| |
|
|
| 7:00 PM |
Opening Remark |
|
| 7:10 PM |
Body of Evidence - SIRTAX,
ISAR-DIABETES, ISAR-DESIRE, ARTS II |
Martin B. Leon, MD |
| 7:30 PM |
REALITY Head-To-Head
Comparison |
Alexandre Abizaid, MD |
| 7:50 PM |
Safety and Efficacy of
Cypher on Complex Lesion |
Seung-Jung Park, MD |
| 8:10 PM |
Is Sirolimus Different
from Analogues? |
Robert Falotico, MD |
| 8:30 PM |
Discussion and Q&A |
|
| |
|
|
|
|
| |
| Friday
|
April 29, 2005 |
Main
Arena
Vista Hall, W-Hotel, Level B2
8:30 AM~6:00 PM |
Live
Case Session 2
Columbia University Medical Center, New York,
USA |
| Moderators:
Martin B. Leon, MD, Gregg W. Stone, MD |
| 8:30 AM |
| Discussants: |
Alexandre Abizaid,
MD
Ted Feldman, MD
Kyoo-Rok Han, MD
Kwon-Bae Kim, MD
Michael Kang-Yin Lee, MD
Yean-Leng Lim, MD
Gary S. Mintz, MD
Seong-Wook Park, MD
Seung-Jung Park, MD
Hideo Tamai, MD |
|
| |
|
| State-of-the-Art
Lectures 1 |
| Moderator:
Dong Joo Oh, MD |
| 10:00 AM |
Percutaneous
Heart Valve Therapy
|
Martin B.
Leon, MD |
| 10:15 AM |
Virtual Histology - A
Technical and Clinical Update |
Gary S. Mintz, MD |
|
|
Live
Case Session 3
The Catholic University, St. Mary's Hospital,
Seoul, Korea
Asan Medical Center, Seoul, Korea : Cases
#3, #4, #5 |
| Moderators:
Ted Feldman, MD, Seong-Wook Park, MD |
| 10:30 AM |
| Discussants: |
Anthony Fung,
MD
Mun Kyung Hong, MD
Man-Hong Jim, MD
Duk-Kyung Kim, MD
Jeong Hyun Kim, MD
Richard E. Kuntz, MD
Richard Ng, MD
John Ormiston, MD
Keum Soo Park, MD
Shigeru Saito, MD |
|
| |
|
|
| State-of-the-Art
Lectures 2 |
| Moderator:
Young-Bae Park, MD |
| 12:00 PM |
What Are the Clinical Gaps and Unanswered
Questions for DES in 2005 ? |
David R. Holmes, Jr,
MD |
| 12:15 PM |
Pathology of Vulnerable Plaque |
Renu Virmani, MD |
| |
|
|
| 12:30
PM |
Lunchtime Activities |
|
|
|
|
Live
Case Session 4
Cardiovascular Institute & Fu Wai Hospital,
Beijing, China
Asan Medical Center, Seoul, Korea : Cases
#6, #7, #8 |
| Moderators:
Seung-Jung Park, MD, Junbo Ge, MD |
| 2:00 PM |
| Discussants: |
Chi Kin Chan,
MD
Yong Huo, MD
Ik-Kyung Jang, MD
Myung-Ho Jeong, MD
Kee-Sik Kim, MD
Takeshi Kimura, MD
Raj R. Makkar, MD
Ian T. Meredith, MD
Shih-Pu Wang, MD |
|
| |
|
|
| State-of-the-Art
Lectures 3 |
| Moderator:
Won-Heum Shim, MD |
| 3:30 PM |
Peripheral Vascular Interventions: What
Is Possible in 2005 ? |
Gerald Dorros, MD |
| 3:45 PM |
Renal Stenting: ASPIRE II , Update on Resist
and CORAL Trial Status |
Krishna Rocha-Singh,
MD |
|
|
|
Live
Case Session 5
San Raffaele Hospital, Milano, Italy |
| Moderators:
Gregg W. Stone, MD, Jean Fajadet, MD |
| 4:00 PM |
| Discussants: |
Paul Chen, MD
David R. Holmes, Jr, MD
I Chang Hsieh, MD
Chong-Jin Kim, MD
Young Dae Kim, MD
Meilin Liu, MD
Gary S. Mintz, MD
Seung-Jung Park, MD
Takehiro Yamashita, MD
Shu Yang Zhang, MD |
|
| 5:40 PM |
Featured Lecture : A Brief Status Update
on REALITY (CYPHER vs TAXUS in Complex Lesions) |
Antonio Colombo, MD |
| |
|
|
| 6:00 PM |
Adjourn |
|
|
Tutorial
Auditorium (How to - What to)
Mugunghwa Hall 1, Sheraton Grande
Walkerhill Seoul Hotel, Level 1
11:00 AM ~ 6:30 PM |
| State of
the Art Lectures 1 |
| Moderator:
Byung-Hee Oh, MD |
11:00 AM
|
The Innovation Revolution:
Next Generation DES Systems |
Martin B. Leon, MD |
| 11:15 AM |
Advanced Tips, Tricks,
and Philosophies for Approaching Difficult
Lesions - A Japanese Perspective |
Hideo Tamai, MD |
|
|
|
Live
Case Session 1
The Catholic University of Korea, St. Mary's
Hospital, Seoul, Korea |
| Moderators:
Martin B. Leon, MD, Hideo Tamai, MD |
| 11:30 AM |
| Discussants: |
Young-Keun Ahn,
MD
In-Ho Chae, MD
Jei Kun Chai, MD
Sameer Indravadan Dani, MD
Gerald Dorros, MD
Shu Kin Li, MD
Sunao Nakamura, MD
Mitsuyasu Terashima, MD |
|
| |
|
|
| 12:30
PM |
Lunchtime
Activities |
|
| |
|
|
| State of
the Art Lectures 2 |
| Moderator:
Eak-Kyun Shin, MD |
| 2:00 PM |
SFA Interventions (Including
New Technique, CTO) |
Krishna Rocha-Singh,
MD |
| 2:15 PM |
The E-valve Edge-to-Edge Repair for Mitral
Regurgitation: Design Concept and EVEREST
Update |
Ted Feldman, MD |
| 2:30 PM |
Carotid Stenting With
Protection Devices |
Paul Hsien-Li Kao, MD |
|
|
|
Live
Case Session 2
Cardiovascular Institute & Fu Wai Hospital,
Beijing, China |
| Moderators:
Jilin Chen, MD, Ki Bae Seung, MD |
| 3:00 PM |
| Discussants: |
Latchumana Dhas,
MD
Ted Feldman, MD
Mujeeb-Ul-Haq, MD
Upendra Kaul, MD
Sang Hoon Lee, MD
Swee Choon Ng, MD
Jeong Euy Park, MD
Alan C. Yeung, MD |
|
|
|
|
Vulnerable
Plaque; How to detect, How to treat
4:00 PM~6:30 PM |
| Moderators:
Ik-Kyung Jang, MD, Richard E. Kuntz, MD |
| 4:00 PM |
Erosion, Intraplaque
Hemorrhage: The Other Face of Vulnerability |
Renu Virmani, MD |
| 4:15 PM |
Characterization of Coronary
Atherosclerotic Plaques Using CTA |
Koen Nieman, MD |
| 4:30 PM |
Structural and Molecular
Magnetic Resonance Imaging of High-Risk Atherosclerosis |
Farouc Jaffer, MD |
| 4:45 PM |
Imaging Inflamed Atherosclerotic
Plaques with Positron Emission Tomography
|
Ahmed Tawakol, MD |
| 5:00 PM |
Coronary Artery Thermography |
Christodoulos Stefanadis,
MD |
| 5:15 PM |
Detection and Treatment
of Thin Fibrous Cap, Lipid Rich, and Inflammatory
Vulnerable Plaque - Angioscopic Evaluation |
Kyoichi Mizuno, MD |
| 5:30 PM |
Intravascular Imaging
Modalities for Detection of Vulnerable Plaque:
IVUS, MR, and OCT |
Ik-Kyung Jang, MD |
| 5:45 PM |
Epidemiologic Stent-Based
Approach to Vulnerable Plaque Stabilization
Based on Statistical Modeling of Plaque Rupture
and Death |
Richard E. Kuntz, MD |
| 6:00 PM |
Regional Photodynamic
Therapy for Vulnerable Plaque Stabilization
I: Antrin |
Alan C. Yeung, MD |
| 6:15 PM |
Preventing and Arresting
Atherosclerosis; Preventing and Arresting
Coronary Atherosclerosis |
William C. Roberts, MD |
| |
|
| 6:30 PM |
Adjourn |
|
|
Breakfast
Meetings
Meet the Experts: Mini-Lectures and Case Discussions
Sheraton Grande Walkerhill Hotel
7:00 AM-8:30 AM |
#1.
Bifurcation Lesions
Art Room, Level 4 |
| Moderators:
John Ormiston, MD, Junbo Ge, MD |
| 7:00 AM |
Bench Insights into Bifurcation
Stenting Strategies. An Update |
John Ormiston, MD |
| 7:10 AM |
Efficacy of FX Minirail
Balloon in Bifurcation Lesions |
Junbo Ge, MD |
| 7:20 AM |
PCI for Bifurcation in
LMT |
Takahiko Suzuki, MD |
| 7:30 AM |
| Case Presentations: |
Seung-Whan Lee,
MD
Deuk-Young Nah, MD
Naoto Inoue, MD |
|
|
|
|
#2.
Drug Eluting Stent Summit - II
Tutorial Auditorium, Level 1 |
| Moderators:
Eberhard Grube, MD, Yean-Teng Lim, MD |
| 7:00 AM |
DES for Bifurcation Lesion |
Yean-Teng Lim, MD |
| 7:10 AM |
Final QCA and 3D-IVUS
Results From a FIM Experience Using an Angiopeptin
PC-Coated Stent |
Vincent On-Hing Kwok,
MD |
| 7:20 AM |
DES for Complex Patients
Subsets |
Alexandre Abizaid, MD |
| 7:30 AM |
Everolimus Drug-Eluting
Stents I: Review of Guidant FUTURE I and II,
and Status Update of FUTURE III and IV |
Eberhard Grube, MD |
| 7:40 AM |
ZoMaxx: Abbott's Drug
Eluting Stent Program |
John Ormiston, MD |
| 7:50 AM |
| Case Presentations: |
Hyun Sook Kim,
MD
Young Joon Hong, MD |
|
|
|
|
#3.
Acute Myocardial Infarction
Cosmos Room, Level 3 |
| Moderators:
Gregg W. Stone, MD, Toshiya Muramatsu, MD |
| 7:00 AM |
EMERALD Trial: Lessons
Learned |
Gregg W. Stone, MD |
| 7:10 AM |
Final Results of ASPARAGAS
Study |
Toshiya Muramatsu, MD |
| 7:20 AM |
Coronary Flow Pattern
and Myocardial Viability: Comparison with
PET |
Seung-Jea Tahk, MD |
| 7:30 AM |
Does Distal Protection?Reduce
Infarct Size During Primary Angioplasty?:
MRI Study |
Hyeon-Cheol Gwon, MD |
| 7:40 AM |
Multivessel versus Single-vessel
Angioplasty During Acute MI |
Mun Kyung Hong, MD |
| 7:50 AM |
| Case Presentations: |
Young-Keun Ahn,
MD
Takehiro Yamashita, MD |
|
|
|
|
#4.
Chronic Total Occlusions
Mugunghwa Room 4, Level 1 |
| Moderators:
James R. Margolis, MD, Kazuaki Mitsudo, MD |
| 7:00 AM |
IVUS Guided Wire Crossing
for CTO |
Takahiko Suzuki, MD |
| 7:10 AM |
PCI for CTO |
Kazuaki Mitsudo, MD |
| 7:20 AM |
Coated vs Non-Coated
Wires for CTO |
James R. Margolis, MD |
| 7:30 AM |
Long Term Result of Cypher
Stenting in CTO |
Hweung Kon Hwang, MD |
| 7:40 AM |
| Case Presentations: |
Nakul Sinha, MD
Yi-Heng Li, MD
Joy M Thomas, MD |
|
|
|
|
#5.
Complex PCI
Calla Room, Level 1 |
| Moderators:
Kenneth Chin, MD, Ki Bae Seung, MD |
| 7:00 AM |
Drug Eluting Stents in
Ostial Lesions |
Kenneth Chin, MD |
| 7:15 AM |
Cypher - LAD Ostial Lesions;
No More Surgery ! |
Ki Bae Seung, MD |
| 7:30 AM |
| Case Presentations: |
Pramod Jaiswal,
MD
Anil Dhall , MD |
|
| |
|
Lunchtime
Activities
Sheraton Grande Walkerhill Seoul
Hotel
12:30 PM-2:00 PM |
#1.
Angiomygenesis
Calla Room, Level 1
Sponsored by Clinical Research Center for
Ischemic Heart disease, The Korea Ministry
of Health and Welfare |
| Moderator:
Hyo-Soo Kim, MD |
| 12:30 PM |
Opening Remark |
Hyo-Soo Kim, MD |
| 12:35 PM |
Stem Cell Biology for
Vasculogenesis |
Takayuki Asahara, MD |
| 1:00 PM |
Novel Modulators of Progenitor
Cell Mobilization |
Kenneth Walsh, MD |
| 1:25 PM |
Angiogenesis Mediated
by Adipose-Derived Stromal Cells: How Fat
Can Be Good |
Keith L. March, MD |
| 1:50 PM |
Q&A |
|
|
|
#2.
Current Standards and Proposed Directions
in Pharmacologic Approaches for PCI
Tutorial Auditorium, Level 1
Sponsored by Bristol-Myers Squibb Company |
| Moderators:
Gregg W Stone, MD, Seung-Jea Tahk, MD |
| 12:30 PM |
Opening Remark |
|
| 12:40 PM |
Metabolic Syndrome, Acute
Coronary Syndrome and Adipocytokines / Q&A
|
Tohru Funahashi, MD |
| 1:00 PM |
Facilitated PCI in AMI |
Seung-Jea Tahk, MD |
| 1:20 PM |
Optimizing Outcomes of
Primary PCI: From CADILLAC to HORIZONS |
Gregg W. Stone, MD |
| 1:40 PM |
Closing Remark |
|
|
|
|
#3.
Lipid Management : A New Era in The Treatment
of Coronary Artery Disease
Mugunghwa Room 4, Level 1
Sponsored by Pfizer Pharmaceuticals Korea
Ltd. |
| Moderator:
Wook-Sung Chung, MD |
| 12:30 PM |
Welcome Address |
Wook-Sung Chung, MD |
| 12:40 PM |
The TNT Trial: Is It
Time to Shift Our Goals in Clinical Practice |
David Colquhoun, MD |
| 1:00 PM |
Early Statin Therapy
in Acute Coronary Syndrome |
Cheol-Whan Lee, MD |
| 1:20 PM |
Beyond the Statin Therapy:
The Importance of HDL Cholesterol |
Ki Hoon Han, MD |
| 1:40 PM |
Q & A |
|
|
|
|
#4.
Drug Eluting Stent Summit - III
Cosmos Room, Level 3
Sponsored by CVRF |
| Moderators:
Gian Battista Danzi, MD, Seong-Wook Park,
MD |
| 12:30 PM |
Update on Jupiter?and?
Clinical Trials with the Sorin Carbostent
Tacrocimus Eluting Stent |
Gian Battista Danzi,
MD |
| 12:45 PM |
Drug-Eluting Biodegradable
Igaki-Tamai Stent |
Hideo Tamai, MD |
| 1:00 PM |
Update on the Endeavor
I-V Trials:?The Latest Results |
Ian T. Meredith, MD |
| 1:15 PM |
Terumo DES Program -Nobori
1 Clinical Trial- |
Hidehiko Honda, MD |
|
|
|
#5.
“Reducing Cardiovascular Risk”
– Keyword in Managing Hypertension and
Lipid
Art Room, Level 4
Sponsored by MSD KOREA LTD. |
| Moderator:
William C. Roberts, MD |
| 12:30 PM |
Welcome Address |
|
| 12:40 PM |
Mechanisms Linking Angiotensin
II & Atherogenesis |
Carlos M. Ferrario, MD |
| 1:00 PM |
The Rationale for Angiotensin
II Receptor Blockers (ARBs) in Human Hypertension:
Based on Correction of Arterial Remodeling
and Endothelial Dysfunction |
Jeong Bae Park, MD |
| 1:20 PM |
Reducing Cardiovascular
Risk Through Intensive Lipid Lowering Therapy:
Lower is Better Through Dual Inhibition |
William C. Roberts, MD |
| 1:40 PM |
Q & A |
|
| |
|
|
|
|
| |
| Saturday
|
April 30, 2005 |
Main
Arena
Vista Hall, W-Hotel, Level B2
8:30 AM~3:45 PM |
Live
Case Session 6
Toyohashi Heart Center, Aichi, Japan
Asan Medical Center, Seoul, Korea : Cases
#9, #10, #11
Pusan National University Hospital, Pusan,
Korea |
| Moderators:
Martin B. Leon, MD, Hideo Tamai, MD |
| 8:30 AM |
| Discussants: |
Yaron Almagor,
MD
Wook-Sung Chung, MD
Luyue Gai, MD
Moo Hyun Kim, MD
Tian-Hai Koh, MD
Kenneth Ka-Hing Lam, MD
James R. Margolis, MD
Chiung-Jen Wu, MD
Junghan Yoon, MD |
|
| |
|
|
| State-of-the-Art
Lectures 4 |
| Moderator:
Seung-Jung Park, MD |
| 10:30 AM |
Evidence-Based Medicine
Analysis of Current DES Clinical Use Guidelines:
A Roadmap for Clinicians |
Gregg W. Stone, MD |
| 10:45 AM |
Plaque Progression and Regression |
James R. Margolis, MD |
|
|
|
Live
Case Session 7
Asan Medical Center, Seoul, Korea : Cases
#12, #13, #14 |
| Moderators:
David R. Holmes, MD, Krishna Rocha-Singh,
MD |
| 11:00 AM |
| Discussants: |
Chien-Ming Huang,
MD
Young Jo Kim, MD
Seung-Hwan Lee, MD
Kazuaki Mitsudo, MD
S.S. Ramesh, MD
Mohd Ali Rosli, MD
Won-Heum Shim, MD
Udayachalerm Wasan, MD
Tetsu Yamaguchi, MD |
|
| |
|
|
| State-of-the-Art
Lectures 5 |
| Moderator:
Dong Joo Oh, MD |
| 12:00 PM |
What Are the Proper End
Points for DES | | | | | |